ClinicalTrials.gg

Program

CBP-0276

A development code. Also written as “CBP-0276 Acetate”, “CBP-0276 capsules 100mg” and “CBP-0276 200mg BID”.

Its studies are mostly in Arthritis, Psoriatic · Psoriasis, led by Clarent Biopharma.

Furthest: phase 2, since Sep 24, 20254 company-led studies, 3 open or runningNext primary completion: Feb 2027 (phase 2)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Clarent Biopharma43 open or runningphase 2since Sep 24, 2025Sep 8, 2025Feb 2027phase 2 · NCT07706530

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Sep 8, 2025First study: phase 1 study in Healthy VolunteersFirst studyNCT07708831 · 64 enrolled · Mexico
  2. Sep 24, 2025Phase 2 study in PsoriasisNCT07204639 · 100 planned · Mexico
  3. Jun 25, 2026Phase 2 study in Hip or Knee ReplacementNCT07687966 · 80 planned · Mexico
  4. Jul 10, 2026Phase 2 study in Arthritis, PsoriaticNCT07706530 · 240 planned · Mexico

Ahead

  1. Feb 2027Primary completion: phase 2 study in Arthritis, PsoriaticNCT07706530

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 4 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07706530Arthritis, Psoriatic · Mexico2Not yet recruitingFeb 2027240
NCT07687966Hip or Knee Replacement · Mexico2RecruitingJun 30, 202680
NCT07204639Psoriasis · Mexico2RecruitingJul 31, 2026100
NCT07708831Healthy Volunteers · Mexico1CompletedFeb 16, 202664

How it is read

Names in the registry

  • “CBP-0276 Acetate”, 1 entry
  • “CBP-0276 capsules 100mg”, 1 entry
  • “CBP-0276”, 1 entry
  • “CBP-0276 200mg BID”, 1 entry

Codes read as this program: CBP0276.

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.